Related Experiment Videos
[Neuronal cell damage in aceruloplasminemia].
1First Department of Medicine, Hamamatsu University School of Medicine, 3600 Handa-cho, Hamamatsu, 431-3192 Japan.
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology
|February 24, 2001
Summary
Aceruloplasminemia, an iron metabolism disorder, causes neurodegeneration and diabetes. Excess iron leads to oxidative stress, damaging brain cells and impairing energy metabolism.
Area of Science:
- Neuroscience
- Metabolic Disorders
- Genetics
Background:
- Aceruloplasminemia is an autosomal recessive disorder impacting iron metabolism.
- It leads to neurodegeneration in the retina and basal ganglia, and diabetes mellitus.
- Neurological symptoms include movement disorders, ataxia, and dementia.
Observation:
- Increased iron concentration in cerebrospinal fluid (CSF) correlates with higher superoxide dismutase activity and lipid peroxidation.
- Brain iron deposition is linked to elevated oxysterol levels (7-hydroxycholesterol, 7-ketocholesterol).
- Positron emission tomography reveals cortical glucose hypometabolism in affected brains.
Findings:
- Iron accumulation acts as a catalyst for biologic oxidation, generating free radicals.
- Mitochondrial respiratory chain complexes I and IV show significant reductions in enzyme activity (62% and 71%).
- These factors contribute to lipid peroxidation and impaired mitochondrial energy metabolism.
Implications:
- Iron-mediated free radical damage is a key mechanism in aceruloplasminemia's pathogenesis.
- Understanding these mechanisms may guide therapeutic strategies for neurodegenerative diseases.
- Further research into iron chelation or antioxidant therapies could be beneficial.